We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
JAMA: The Journal of the American Medical Association
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial
JAMA 2023 Jan 12;[EPub Ahead of Print], MW McCarthy, S Naggie, DR Boulware, CJ Lindsell, TG Stewart, GM Felker, D Jayaweera, M Sulkowski, N Gentile, C Bramante, U Singh, RJ Dolor, J Ruiz-Unger, S Wilson, A DeLong, A Remaly, R Wilder, S Collins, SE Dunsmore, SJ Adam, F Thicklin, G Hanna, AA Ginde, M Castro, K McTigue, E Shenkman, AF Hernandez